Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index- P/E- EPS (ttm)-1.43 Insider Own48.58% Shs Outstand36.61M Perf Week-3.62%
Market Cap75.08M Forward P/E- EPS next Y- Insider Trans-0.91% Shs Float19.54M Perf Month-16.28%
Income-52.15M PEG- EPS next Q- Inst Own12.08% Short Float6.27% Perf Quarter-63.14%
Sales231.67M P/S0.32 EPS this Y- Inst Trans44.15% Short Ratio2.16 Perf Half Y-18.69%
Book/sh1.89 P/B1.05 EPS next Y- ROA-7.74% Short Interest1.22M Perf Year36.75%
Cash/sh1.41 P/C1.40 EPS next 5Y- ROE-28.67% 52W Range1.26 - 5.68 Perf YTD-26.00%
Dividend Est.- P/FCF- EPS past 5Y- ROI-56.66% 52W High-65.21% Beta3.63
Dividend TTM- Quick Ratio0.67 Sales past 5Y-5.45% Gross Margin37.78% 52W Low56.81% ATR (14)0.16
Dividend Ex-Date- Current Ratio0.67 EPS Y/Y TTM72.58% Oper. Margin-4.32% RSI (14)34.52 Volatility6.22% 7.41%
Employees925 Debt/Eq2.04 Sales Y/Y TTM-34.37% Profit Margin-22.51% Recom3.00 Target Price4.00
Option/ShortYes / Yes LT Debt/Eq0.28 EPS Q/Q114.30% Payout- Rel Volume0.48 Prev Close1.94
Sales Surprise- EPS Surprise- Sales Q/Q-12.25% EarningsMar 13 AMC Avg Volume567.23K Price1.98
SMA20-8.81% SMA50-19.69% SMA200-28.26% Trades Volume108,153 Change1.85%
Date Action Analyst Rating Change Price Target Change
Nov-22-22Downgrade Cowen Outperform → Market Perform $3 → $2
Aug-11-22Downgrade BofA Securities Neutral → Underperform $4.50 → $2
Feb-04-22Initiated BofA Securities Neutral $5
Jan-12-22Initiated Craig Hallum Buy $7.50
Jan-10-22Initiated Cowen Outperform $7
Feb-11-25 11:06AM
Dec-12-24 09:05AM
Nov-12-24 04:40PM
Oct-08-24 04:30PM
Aug-12-24 04:19PM
05:08PM Loading…
Jul-16-24 05:08PM
Jul-11-24 04:30PM
Jun-28-24 03:34PM
Jun-27-24 10:05AM
Jun-24-24 04:09PM
11:27AM
Jun-20-24 07:15AM
Jun-18-24 02:30PM
06:30AM
Jun-09-24 02:09PM
07:00AM Loading…
Jun-06-24 07:00AM
May-28-24 02:56PM
May-22-24 02:52PM
12:34PM
12:19PM
12:11PM
10:41AM
09:42AM
May-17-24 09:00AM
May-13-24 09:53PM
04:37PM
01:59PM
May-02-24 11:30AM
Apr-22-24 04:30PM
Apr-16-24 12:18PM
10:58AM Loading…
10:58AM
Mar-28-24 10:04AM
Mar-27-24 11:24AM
Mar-26-24 12:50PM
Mar-25-24 09:52PM
04:32PM
12:53PM
Mar-19-24 05:52PM
Feb-22-24 11:29AM
08:14AM
Feb-21-24 04:05PM
Feb-15-24 03:16PM
Nov-12-23 08:39AM
Nov-03-23 11:05AM
Nov-02-23 04:30PM
Oct-31-23 03:50PM
Oct-26-23 04:30PM
Sep-26-23 01:09PM
Sep-18-23 12:29PM
Sep-15-23 03:01AM
Aug-08-23 04:10PM
Jul-29-23 11:24AM
Jul-11-23 11:16AM
Jun-29-23 04:05PM
Jun-22-23 10:50AM
Jun-20-23 09:00AM
Jun-13-23 09:00PM
Jun-05-23 12:00PM
May-24-23 09:00AM
May-23-23 09:35AM
May-15-23 03:58PM
08:54AM
May-11-23 04:15PM
May-10-23 07:22AM
May-09-23 05:10PM
04:20PM
May-03-23 04:15PM
May-02-23 02:33PM
Apr-21-23 06:35PM
Apr-20-23 10:10PM
04:58PM
03:43PM
12:05PM
11:51AM
Apr-11-23 08:35AM
Mar-17-23 07:11PM
Mar-15-23 09:09AM
Mar-13-23 04:31PM
Feb-16-23 05:30AM
Feb-14-23 04:05PM
01:38PM
09:15AM
Feb-02-23 03:08PM
10:30AM
Jan-27-23 04:51PM
03:58PM
04:48AM
04:48AM
Jan-26-23 06:38PM
03:57PM
01:29PM
Jan-25-23 07:41PM
Jan-20-23 03:06PM
Dec-07-22 04:05PM
Dec-06-22 01:13PM
Nov-16-22 05:10AM
Nov-14-22 04:30PM
Oct-28-22 07:51PM
Oct-04-22 08:30AM
Sep-20-22 02:45PM
Buzzfeed, Inc. is an independent digital media company, which engages in engagement, distribution, and leveraging data. Its cross-platform network includes BuzzFeed Originals, which creates articles, lists, quizzes, and videos, BuzzFeed Media Brands, which consists of a portfolio of identity-driven lifestyle brands including Nifty, Goodful, As/Is, and Tasty, a social food network, BuzzFeed Studios, which produces original content across broadcast, cable, SVOD, film and digital platforms, and BuzzFeed News and HuffPost, which include reporting and investigative journalism, and BuzzFeed Commerce, which develops products and experiences, as well as licensing and other strategic partnerships. The company was founded by Jonah Peretti and John Johnson in November 2006 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KERINS PATRICK J10% OwnerMar 07 '25Sale2.0633,84869,6023,778,094Mar 11 07:25 PM
KERINS PATRICK J10% OwnerMar 11 '25Sale1.9513,62926,6203,764,465Mar 11 07:25 PM
NEW ENTERPRISE ASSOCIATES 13 L10% OwnerMar 07 '25Sale2.0633,84869,6023,778,094Mar 11 06:53 PM
NEW ENTERPRISE ASSOCIATES 13 L10% OwnerMar 11 '25Sale1.9513,62926,6203,764,465Mar 11 06:53 PM
Omer MatthewCFOMar 05 '25Option Exercise0.001,6660179,554Mar 07 07:57 PM
Arroyo DavidCLOMar 05 '25Option Exercise0.0025,1440113,206Mar 07 07:56 PM
KERINS PATRICK J10% OwnerMar 06 '25Sale2.1011,12723,3723,811,942Mar 06 09:08 PM
KERINS PATRICK J10% OwnerMar 05 '25Sale2.048,96618,2663,823,069Mar 06 09:08 PM
KERINS PATRICK J10% OwnerMar 04 '25Sale2.071,4382,9783,832,035Mar 06 09:08 PM
NEW ENTERPRISE ASSOCIATES 13 L10% OwnerMar 06 '25Sale2.1011,12723,3723,811,942Mar 06 09:05 PM
NEW ENTERPRISE ASSOCIATES 13 L10% OwnerMar 05 '25Sale2.048,96618,2663,823,069Mar 06 09:05 PM
NEW ENTERPRISE ASSOCIATES 13 L10% OwnerMar 04 '25Sale2.071,4382,9783,832,035Mar 06 09:05 PM
Rolle Janet LDirectorMar 01 '25Option Exercise0.0011,8960134,800Mar 04 06:54 PM
Rothstein AdamDirectorMar 01 '25Option Exercise0.0016,6550839,734Mar 04 06:53 PM
COLEMAN GREGORYDirectorMar 01 '25Option Exercise0.0011,8960339,993Mar 04 06:53 PM
Acharia AngelaDirectorMar 01 '25Option Exercise0.0011,8960138,824Mar 04 06:53 PM
Rothstein AdamDirectorJan 01 '25Option Exercise0.0047,6370823,079Jan 02 06:42 PM
Rolle Janet LDirectorDec 13 '24Sale3.5030,801107,662122,904Dec 17 04:37 PM
COLEMAN GREGORYDirectorDec 01 '24Option Exercise0.0019,2280328,097Dec 02 07:09 PM
Acharia AngelaDirectorDec 01 '24Option Exercise0.0019,2280126,928Dec 02 07:09 PM
Rolle Janet LDirectorDec 01 '24Option Exercise0.0019,2280153,705Dec 02 07:09 PM
Rothstein AdamDirectorDec 01 '24Option Exercise0.0026,9190775,442Dec 02 07:09 PM
Weinstein DanielChief Accounting OfficerNov 15 '24Option Exercise0.003,749013,339Nov 19 05:43 PM
Arroyo DavidCLONov 15 '24Option Exercise0.0025,845098,481Nov 19 05:43 PM
Omer MatthewCFONov 15 '24Option Exercise0.0062,0850200,043Nov 19 05:42 PM
Rolle Janet LDirectorNov 15 '24Option Exercise0.001,6740134,477Nov 19 05:42 PM
Rothstein AdamDirectorOct 01 '24Option Exercise0.0047,6370748,523Oct 04 06:00 PM
Rolle Janet LDirectorSep 01 '24Option Exercise0.0019,2280132,803Sep 05 06:42 AM
Acharia AngelaDirectorSep 01 '24Option Exercise0.0019,2280107,700Sep 05 06:42 AM
COLEMAN GREGORYDirectorSep 01 '24Option Exercise0.0019,2280308,869Sep 05 06:41 AM
Rothstein AdamDirectorSep 01 '24Option Exercise0.0026,9190700,886Sep 05 06:41 AM
Arroyo DavidCLOAug 15 '24Option Exercise0.00704072,921Aug 16 08:29 PM
Rolle Janet LDirectorAug 15 '24Option Exercise0.001,6740113,575Aug 16 08:28 PM
Omer MatthewCFOAug 15 '24Option Exercise0.0060,4180159,518Aug 16 08:28 PM
Rothstein AdamDirectorJul 01 '24Option Exercise0.0076,9110673,967Jul 03 05:15 PM
Rothstein AdamDirectorJun 01 '24Option Exercise0.0035,2500597,056Jun 04 06:42 PM
Acharia AngelaDirectorJun 01 '24Option Exercise0.0019,228088,472Jun 04 06:42 PM
Rolle Janet LDirectorJun 01 '24Option Exercise0.0019,2280111,901Jun 04 06:42 PM
COLEMAN GREGORYDirectorJun 01 '24Option Exercise0.0019,2280289,641Jun 04 06:41 PM
Johnson John S. IIIMember of 10% GroupMay 31 '24Sale2.85104,000296,0671,091,195Jun 04 06:41 PM
Arroyo DavidCLOMay 21 '24Option Exercise0.00101,9780113,319May 23 07:43 PM
Weinstein DanielChief Accounting OfficerMay 21 '24Option Exercise0.0014,999014,999May 23 07:42 PM
Omer MatthewCFOMay 21 '24Option Exercise0.00127,5030144,599May 23 07:42 PM
COMCAST CORP10% OwnerMay 22 '24Sale3.193,176,92310,145,8212,000,000May 23 04:40 PM
Rolle Janet LDirectorMay 15 '24Option Exercise0.001,674092,673May 17 05:51 PM
Rothstein AdamDirectorApr 29 '24Option Exercise0.00415,31802,247,222May 01 06:00 PM
COLEMAN GREGORYDirectorApr 29 '24Option Exercise0.0076,91001,081,649May 01 05:59 PM
Acharia AngelaDirectorApr 29 '24Option Exercise0.0076,9100276,975May 01 05:59 PM
Rolle Janet LDirectorApr 29 '24Option Exercise0.0076,9100363,993May 01 05:59 PM
Last Close
Mar 12 11:54AM ET
3.44
Dollar change
+0.05
Percentage change
1.33
%
SGMT Sagimet Biosciences Inc daily Stock Chart
Index- P/E- EPS (ttm)-1.29 Insider Own27.72% Shs Outstand30.67M Perf Week-6.01%
Market Cap105.52M Forward P/E- EPS next Y-5.25 Insider Trans0.00% Shs Float23.27M Perf Month-24.73%
Income-37.52M PEG- EPS next Q-0.81 Inst Own41.56% Short Float21.38% Perf Quarter-32.55%
Sales0.00M P/S- EPS this Y-152.30% Inst Trans-13.90% Short Ratio5.11 Perf Half Y9.21%
Book/sh5.30 P/B0.65 EPS next Y-43.58% ROA-27.02% Short Interest4.98M Perf Year-40.17%
Cash/sh4.97 P/C0.69 EPS next 5Y- ROE-27.94% 52W Range2.39 - 7.38 Perf YTD-23.56%
Dividend Est.- P/FCF- EPS past 5Y-16.23% ROI-21.98% 52W High-53.39% Beta2.29
Dividend TTM- Quick Ratio38.34 Sales past 5Y0.00% Gross Margin- 52W Low43.93% ATR (14)0.33
Dividend Ex-Date- Current Ratio38.34 EPS Y/Y TTM- Oper. Margin- RSI (14)37.61 Volatility7.77% 8.35%
Employees10 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price38.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-53.03% Payout- Rel Volume0.25 Prev Close3.39
Sales Surprise- EPS Surprise19.52% Sales Q/Q-100.00% EarningsMar 12 BMO Avg Volume974.15K Price3.44
SMA20-9.97% SMA50-20.41% SMA200-17.94% Trades Volume97,176 Change1.33%
Date Action Analyst Rating Change Price Target Change
Dec-06-24Initiated Oppenheimer Outperform $30
Nov-12-24Initiated UBS Buy $12
Jun-28-24Downgrade Goldman Buy → Neutral $23 → $6
May-02-24Initiated H.C. Wainwright Buy $32
Mar-25-24Initiated Leerink Partners Outperform $26
Aug-08-23Initiated TD Cowen Outperform
Aug-08-23Initiated Piper Sandler Overweight $67
Aug-08-23Initiated JMP Securities Mkt Outperform $30
Aug-08-23Initiated Goldman Buy $33
Today 07:30AM
Mar-11-25 08:00AM
Feb-25-25 08:25AM
Feb-22-25 05:24PM
Feb-19-25 08:00AM
08:00AM Loading…
Jan-06-25 08:00AM
Dec-15-24 06:04AM
Nov-26-24 08:00AM
Nov-18-24 08:00AM
Nov-14-24 08:00AM
Nov-12-24 06:30AM
Nov-07-24 07:30AM
Oct-29-24 07:00AM
Oct-16-24 07:00AM
Oct-11-24 07:00AM
07:00AM Loading…
Oct-01-24 07:00AM
12:05AM
Sep-12-24 07:30AM
Sep-04-24 08:00AM
Aug-14-24 08:00AM
Aug-01-24 08:00AM
Jun-10-24 08:00AM
Jun-06-24 05:00AM
May-16-24 08:00AM
May-15-24 12:53PM
08:00AM
May-07-24 08:00AM
May-06-24 08:00AM
Apr-22-24 08:00AM
Mar-27-24 04:01PM
07:00AM Loading…
Mar-25-24 07:00AM
06:15AM
Feb-29-24 08:00AM
Jan-25-24 08:58PM
Jan-23-24 05:45PM
Jan-22-24 11:10PM
07:00AM
Dec-04-23 08:00AM
Nov-28-23 08:00AM
Nov-22-23 08:00AM
Nov-13-23 08:00AM
Nov-10-23 08:30AM
Oct-24-23 11:00AM
Oct-18-23 04:05PM
Sep-27-23 04:05PM
Aug-29-23 10:21AM
Aug-21-23 04:02PM
Aug-15-23 04:04PM
Aug-08-23 10:02AM
Jul-20-23 04:05PM
Jul-13-23 09:10PM
Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kemble GeorgeExecutive ChairmanJul 23 '24Sale3.1723,62574,830118,693Jul 25 04:05 PM
Martins Eduardo BrunoChief Medical OfficerJul 19 '24Sale3.108,35725,91081,213Jul 23 04:06 PM
Rozek ElizabethGeneral Counsel and CCOJul 19 '24Sale3.1010,91433,830160,506Jul 23 04:05 PM
Kemble GeorgeExecutive ChairmanJul 19 '24Sale3.1014,06243,605142,318Jul 23 04:05 PM
Happel DavidPresident & CEOMar 26 '24Buy5.2712,10063,731639,200Mar 28 04:08 PM